Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Afatinib × 1 year × Clear all

Sponsor

Conditions

Head and Neck Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Cancers of the Head and Neck 1 Recurrence 1 Pancreatic Neoplasms 1 Neoplasms 1 NSCLC Harboring NRG1 Fusion 1 Multiple Myeloma 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Advanced Squamous Non Small Cell Lung Cancer 1 Advanced Solid Tumors 1

Interventions

Cisplatin 5 pembrolizumab 4 durvalumab 4 Pemetrexed 4 palbociclib 3 Nivolumab 3 Fulvestrant 3 Carboplatin 3 Anastrozole 3 130-nm albumin-bound paclitaxel 3 selpercatinib 2 ribociclib 2 pralsetinib 2 cobimetinib 2 atezolizumab 2 abemaciclib 2 Vemurafenib 2 Radiosurgery 2 Paclitaxel 2 Letrozole 2 Gonadotropin-Releasing Hormone 2 Bevacizumab 2 Ascorbic Acid 2 AZD9833 2 trametinib 1 taletrectinib 1 spartalizumab 1 sotorasib 1 repotrectinib 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡